SEC Form 4 · accession 0000899243-18-012078
Apellis Pharmaceuticals, Inc. · APLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cedric Francois
Officer — Chief Executive Officer · Director
Period of report
May 7, 2018
Accepted (ET)
May 9, 2018 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492422
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2018 | J | 384,292 | $0.00 | A | 714,288 | D | |
| Common StockF2 | holding | — | — | — | 234,411 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution from Potentia Holdings, LLC, of which the reporting person is the chief executive officer and a member of the board of directors.
- F2The securities are held by The Francois-DuBois Educational Trust (the "Trust"), for which Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.